Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”

Bibliographic Details
Main Authors: Todtenkopf Mark S. PhD, Correll Christoph U. MD, Harris-White Marni E. PhD, Doane Michael J. PhD, McDonnell David MD
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2023-08-01
Series:Mental Health Clinician
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2023.08.196
_version_ 1797383342266515456
author Todtenkopf Mark S. PhD
Correll Christoph U. MD
Harris-White Marni E. PhD
Doane Michael J. PhD
McDonnell David MD
author_facet Todtenkopf Mark S. PhD
Correll Christoph U. MD
Harris-White Marni E. PhD
Doane Michael J. PhD
McDonnell David MD
author_sort Todtenkopf Mark S. PhD
collection DOAJ
first_indexed 2024-03-08T21:18:39Z
format Article
id doaj.art-ace885a046994abb9440e4443ef7e877
institution Directory Open Access Journal
issn 2168-9709
language English
last_indexed 2024-03-08T21:18:39Z
publishDate 2023-08-01
publisher American Association of Psychiatric Pharmacists
record_format Article
series Mental Health Clinician
spelling doaj.art-ace885a046994abb9440e4443ef7e8772023-12-21T12:17:22ZengAmerican Association of Psychiatric PharmacistsMental Health Clinician2168-97092023-08-0113419619710.9740/mhc.2023.08.196i2168-9709-13-4-196Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”Todtenkopf Mark S. PhD0https://orcid.org/0000-0003-4764-7816Correll Christoph U. MD1https://orcid.org/0000-0002-7254-5646Harris-White Marni E. PhD2https://orcid.org/0000-0001-8994-3715Doane Michael J. PhD3https://orcid.org/0009-0006-6102-2459McDonnell David MD4https://orcid.org/0000-0002-6400-12861 Director, Scientific Communications, Alkermes Inc, Waltham, Massachusetts2 Professor of Psychiatry, The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York; Professor of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York; Professor of Child and Adolescent Psychiatry and Department Chair, Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany3 Medical Director, Medical Affairs Strategy, Alkermes Inc, Waltham, Massachusetts4 Director, Health Economics & Outcomes Research, Alkermes Inc, Waltham, Massachusetts5 Executive Medical Director, Alkermes Pharma Ireland Ltd, Dublin, Irelandhttps://theijpt.org/doi/pdf/10.9740/mhc.2023.08.196
spellingShingle Todtenkopf Mark S. PhD
Correll Christoph U. MD
Harris-White Marni E. PhD
Doane Michael J. PhD
McDonnell David MD
Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
Mental Health Clinician
title Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
title_full Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
title_fullStr Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
title_full_unstemmed Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
title_short Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
title_sort comment on opioid antagonists to prevent olanzapine induced weight gain a systematic review
url https://theijpt.org/doi/pdf/10.9740/mhc.2023.08.196
work_keys_str_mv AT todtenkopfmarksphd commentonopioidantagoniststopreventolanzapineinducedweightgainasystematicreview
AT correllchristophumd commentonopioidantagoniststopreventolanzapineinducedweightgainasystematicreview
AT harriswhitemarniephd commentonopioidantagoniststopreventolanzapineinducedweightgainasystematicreview
AT doanemichaeljphd commentonopioidantagoniststopreventolanzapineinducedweightgainasystematicreview
AT mcdonnelldavidmd commentonopioidantagoniststopreventolanzapineinducedweightgainasystematicreview